AcquisitionOther
G1 Therapeutics, Inc. acquired G1 Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
G1 Therapeutics, Inc. -> G1 Therapeutics · $7.15
Together, Pharmacosmos and G1 Therapeutics will execute on the shared vision to grow and accelerate the availability of COSELA for all appropriate patients with ES-SCLC.
Open source record (SEC) ↗